tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

BioAtla price target lowered to $10 from $13 at BTIG

BTIG lowered the firm’s price target on BioAtla (BCAB) to $10 from $13 and keeps a Buy rating on the shares. The firm is updating its model to reflect the company’s December equity raise, the analyst tells investors in a research note.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1